Naltrexone: A Promising Treatment for Schizophrenia
This article explores the potential of naltrexone as a treatment option for schizophrenia. It covers the basics of naltrexone, its mechanism, and its effects on schizophrenia symptoms. The piece also delves into clinical studies and practical tips for those considering this treatment. Discover if naltrexone could be a game-changer in mental health care.
Sep, 5 2024
Eli Lilly's New Parkinson's Drug Shows Significant Promise in Clinical Trials
Eli Lilly’s experimental drug, LY344867, has shown notable success in a mid-stage clinical trial. The medication, aimed at slowing Parkinson's disease progression, revealed significant improvements in motor function among early-stage patients. Over 12 months, 180 patients participated, with those on LY344867 experiencing a 35% reduction in motor symptoms. The promising data was presented at a major medical conference.
Aug, 17 2024